Literature DB >> 22786724

Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.

Hun Sik Kim1, Eric O Long.   

Abstract

The cytotoxic effects of natural killer (NK) cells and their ability to secrete cytokines require synergistic signals from specific pairs of co-activation receptors, such as CD314 (also known as NKG2D) and CD244 (2B4), which bind to distinct ligands present on target cells. These signals are required to overcome inhibition mediated by the E3 ubiquitin ligase c-Cbl of the guanine nucleotide exchange factor Vav1, which promotes activation of NK cells. Here, we showed that the adaptor protein SLP-76 (Src homology 2 domain-containing leukocyte phosphoprotein of 76 kilodaltons) was required for this synergy and that distinct tyrosine residues in SLP-76 were phosphorylated by each member of a pair of synergistic receptors. Selective phosphorylation of tyrosine 113 or tyrosine 128 in SLP-76 enabled binding of SLP-76 to Vav1. Selective phosphorylation of SLP-76 at these residues was restricted to receptors that stimulated ligand-dependent target cell killing; antibody-dependent stimulation of the Fc receptor CD16 promoted phosphorylation at both sites. Knockdown and reconstitution experiments with SLP-76 mutant proteins showed the distinct role of each tyrosine in the synergistic mobilization of Ca2+, revealing an unexpected degree of selectivity in the phosphorylation of SLP-76 by NK cell co-activation receptors. Together, these data suggest that combined phosphorylation of separate tyrosine residues in SLP-76 forms the basis of synergistic NK cell activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22786724      PMCID: PMC3842037          DOI: 10.1126/scisignal.2002754

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  57 in total

Review 1.  Vav proteins, adaptors and cell signaling.

Authors:  X R Bustelo
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

2.  Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.

Authors:  T S Manetz; C Gonzalez-Espinosa; R Arudchandran; S Xirasagar; V Tybulewicz; J Rivera
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 3.  VAV proteins as signal integrators for multi-subunit immune-recognition receptors.

Authors:  Martin Turner; Daniel D Billadeau
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

Review 4.  Adaptors as central mediators of signal transduction in immune cells.

Authors:  Martha S Jordan; Andrew L Singer; Gary A Koretzky
Journal:  Nat Immunol       Date:  2003-02       Impact factor: 25.606

5.  Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Authors:  Christopher C Stebbins; Carsten Watzl; Daniel D Billadeau; Paul J Leibson; Deborah N Burshtyn; Eric O Long
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Authors:  D Cosman; J Müllberg; C L Sutherland; W Chin; R Armitage; W Fanslow; M Kubin; N J Chalupny
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

7.  Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

Authors:  D Pende; C Cantoni; P Rivera; M Vitale; R Castriconi; S Marcenaro; M Nanni; R Biassoni; C Bottino; A Moretta; L Moretta
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

8.  NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.

Authors:  Daniel D Billadeau; Jadee L Upshaw; Renee A Schoon; Christopher J Dick; Paul J Leibson
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

9.  Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways.

Authors:  Lucinda F Reynolds; Lesley A Smyth; Trisha Norton; Norman Freshney; Julian Downward; Dimitris Kioussis; Victor L J Tybulewicz
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.

Authors:  Cristina Bottino; Roberta Castriconi; Daniela Pende; Paola Rivera; Marina Nanni; Barbara Carnemolla; Claudia Cantoni; Jessica Grassi; Stefania Marcenaro; Nicolas Reymond; Massimo Vitale; Lorenzo Moretta; Marc Lopez; Alessandro Moretta
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  30 in total

Review 1.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

2.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Anna Rünzi; Tanja Kuhlmann; Anita Posevitz-Fejfár; Nicholas Schwab; Tilman Schneider-Hohendorf; Sebastian Herich; Kathrin Held; Matea Konjević; Marvin Hartwig; Klaus Dornmair; Reinhard Hohlfeld; Tjalf Ziemssen; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 3.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

Review 4.  Natural killer cell cytotoxicity and its regulation by inhibitory receptors.

Authors:  Santosh Kumar
Journal:  Immunology       Date:  2018-04-11       Impact factor: 7.397

5.  Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage.

Authors:  Jason L Pugh; Neda Nemat-Gorgani; Paul J Norman; Lisbeth A Guethlein; Peter Parham
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

Review 6.  Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.

Authors:  Peng Xiong; Hai-Wei Sang; Min Zhu
Journal:  Immunology       Date:  2015-09-28       Impact factor: 7.397

7.  PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity.

Authors:  Jacqueline Moebius; Rajan Guha; Mary Peterson; Kaveh Abdi; Jeff Skinner; Shanping Li; Gunjan Arora; Boubacar Traore; Sumati Rajagopalan; Eric O Long; Peter D Crompton
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

Review 8.  Controlling natural killer cell responses: integration of signals for activation and inhibition.

Authors:  Eric O Long; Hun Sik Kim; Dongfang Liu; Mary E Peterson; Sumati Rajagopalan
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

9.  Signaling for synergistic activation of natural killer cells.

Authors:  Hyung-Joon Kwon; Hun Sik Kim
Journal:  Immune Netw       Date:  2012-12-31       Impact factor: 6.303

10.  Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation.

Authors:  Payal Dhar; Fahmin Basher; Zhe Ji; Lei Huang; Si Qin; Derek A Wainwright; Jerid Robinson; Shaye Hagler; Jing Zhou; Sean MacKay; Jennifer D Wu
Journal:  Commun Biol       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.